Background: To report the occurrence of concentric fibrillary lines in the central corneas of a 13-year-old girl during overnight orthokeratology.
Methods: Observational case report.
Results: The initial refractive errors and keratometric readings (flattest/steepest meridians) of the patient were -6.00/-0.50 x 180 and 45.25/46.20 D, respectively, in the right eye and -5.50 DS and 44.90/45.80 D, respectively in the left eye. She underwent orthokeratology for myopic control, with a target reduction of 4.00 D myopia. A pair of DreimLens lenses was prescribed to be worn on a nightly basis and spectacles were worn by day. The same orthokeratology lenses were used throughout the monitoring period. Corneal topography showed well-centred treatment zones but persistent peripheral corneal staining due to trichiasis. A faint, peripheral pigmented brownish corneal arc and bundles of fine concentric fibrillary lines were observed in the central cornea about 12 months after commencing lens wear. In view of the persistent corneal staining due to trichiasis, she was advised to stop the orthokeratology treatment after 16 months of lens wear and was prescribed 1-Day Acuvue daily disposable contact lenses. The pigmented line disappeared after 2 months of hydrogel lens wear, while the fibrillary lines took 10 months to resolve.
Conclusions: Fibrillary lines are a feature of the normal cornea thought to represent the arrangement of the subbasal, epithelial nerve plexus. We hypothesize that orthokeratology lens wear stimulates an altered epithelial migration pattern and a structural reorganisation of the subbasal nerve plexus in relation to this. This is assumed to account for the concentric pattern of fibrillary lines seen in our patient. The lines had no effect on vision and resolved over a period of 10 months following cessation of orthokeratology lens wear.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1475-1313.2006.00395.x | DOI Listing |
Alzheimers Res Ther
December 2024
Faculty of Health, Medicine and Life Sciences, Mental Health and Neuroscience Research Institute, Alzheimer Centre Limburg, Maastricht University, Maastricht, The Netherlands.
Background: Although separate lines of research indicated a moderating role of sex in both sleep-wake disruption and in the interindividual vulnerability to Alzheimer's disease (AD)-related processes, the quantification of sex differences in the interplay between sleep-wake dysregulation and AD pathology remains critically overlooked. Here, we examined sex-specific associations between circadian rest-activity patterns and AD-related pathophysiological processes across the adult lifespan.
Methods: Ninety-two cognitively unimpaired adults (mean age = 59.
Geroscience
November 2024
David B. Kriser Dental Center, Department of Molecular Pathobiology, New York University College of Dentistry, 345 East 24Th Street, New York, NY, 10010-4086, USA.
Several mouse lines with congenital growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis disruption have shown improved health and extended lifespan. The current study investigated how inactivating this axis, specifically during aging, impacts the healthspan. We used a tamoxifen-inducible global GH receptor (GHR) knockout mouse model starting at 12 months and followed the mice until 24 months of age (iGHRKO mice).
View Article and Find Full Text PDFAdv Exp Med Biol
October 2024
Rostov State Transport University, Rostov-on-Don, Russia.
Exp Neurol
October 2024
Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena 41125, Italy. Electronic address:
The COVID-19, caused by SARS-CoV-2, first affects the respiratory tract but evidence is emerging that the virus, reaching the central nervous system (CNS), can lead to severe neurological disorders. In particular, CoV infection could cause an acceleration of the neurodegenerative process. On the other hand, patients diagnosed with Alzheimer's disease (AD) develop more serious forms of COVID-19 with worse relapses.
View Article and Find Full Text PDFJBMR Plus
July 2024
Academic Endocrine Unit, Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Churchill Hospital, Headington, Oxford OX3 7LJ, United Kingdom.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!